JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia. (Q39779519)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia. |
scientific article |
Statements
JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia (English)
Carl L Manthey
Dana L Johnson
Carl R Illig
Robert W Tuman
Zhao Zhou
Judith F Baker
Margery A Chaikin
Robert R Donatelli
Carol F Franks
Lee Zeng
Carl Crysler
Yanmin Chen
Edward J Yurkow
Lisa Boczon
Sanath K Meegalla
Kenneth J Wilson
Mark J Wall
Jinsheng Chen
Shelley K Ballentine
Heidi Ott
Christian Baumann
Danielle Lawrence
Bruce E Tomczuk
3 November 2009